BackOrion Biotech Opportunities Overview

Orion Biotech Opportunities Receivables

Latest receivables for ORIA: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Orion Biotech Opportunities Receivables History

Loading

Orion Biotech Opportunities vs. peers: Receivables Comparison

Loading

Orion Biotech Opportunities Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Orion Biotech Opportunities (ORIA) FAQ

As of the most recent data (December 2022), ORIA shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORIA's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities is outperforming or lagging.

Tracking ORIA's receivables over time shows whether Orion Biotech Opportunities is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Orion Biotech Opportunities's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.